Back to search

Belgium· BE-AMP-SAM255001-00

Apocard Retard 100 mg

A flecainide product containing flecainide acetate, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 18 of our 19 countries.

ATC C01BC04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedApocard Retard 100 mgATCC01BC04REGISTER NO.BE-AMP-SAM255001-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Flecainide is registered in 18 of 19 countries.

Countries holding a registration under ATC C01BC04 (flecainide), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 11 of them publish a price we can compare per daily dose

Flecainide · ATC C01BC04

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flecainide costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), the median price runs from $0.49 in France to $2.20 in Switzerland — a ×4.5 gap.

  • 4 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Flecainide · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$2.20
  • IT Italy$0.70
  • ES Spain$0.61
  • FR France$0.49
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Flecainide Acetate
Manufacturer
Viatris Healthcare
Country
Belgium (BE)
ATC code
C01BC04
ATC class
Flecainide
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    2076123
    EUR 25.55
  • be_apb
    0776039

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

342 interactions on record for flecainide.

Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Flecainide · interactions on record

342 records

  • 42 severe
  • 164 moderate
  • 15 minor
  • 75 info

Most severe, free to view

  • PapaverineA03AD01severe
  • CisaprideA03FA02severe
  • DolasetronA04AA04severe
  • EliglustatA16AX10severe

46 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flecainide in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flecainide products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Aristocor
  • Bulgaria · Амаритон, Фелкарид
  • Cyprus · Flecardia
  • Czechia · Amarhyton, Amarhyton 100 Mg
  • Germany · Flecadura, Flecainid
  • Denmark · Flecainid Sandoz, Flecainid Stada
  • Spain · Apocard, Flecainida Aurovitas
  • Finland · Flecainide Orion, Tambocor
  • France · Flecaine, Flecaine L.P.
  • United Kingdom (Northern Ireland) · Flecainide Acetate Accord-Uk, Flecainide Acetate Brown & Burk Uk
  • Greece · Amarhyton, Flecainide/Flexmed
  • Croatia · Felkarid
  • Ireland · Flecainide Teva, Tambocor
  • Iceland · Flecainid Stada, Tambocor
  • Italy · Almarytm, Flecainide Aurobindo
  • Luxembourg · Apocard Retard, Flecainide Retard Eg
  • Malta · Flecainide Acetate Aurobindo Pharma (Malta), Tambocor
  • Netherlands · Flecainide Acetate Aurobindo, Flecainide Acetate Ratiopharm
  • Norway · Flecainid Sandoz, Tambocor
  • Poland · Flecainide Acetate Holsten
  • Portugal · Amarhyton, Apocard
  • Romania · Amarhyton, Tambocor
  • Sweden · Tambocor, Tambocor Retard
  • Slovenia · Felkarid
  • Slovakia · Amarhyton 100 Mg, Amarhyton 50 Mg

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/ae139323-e600-4c1e-8598-ff1967eb058d
GET /v1/drugs/ae139323-e600-4c1e-8598-ff1967eb058d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Prolonged-release capsule, hard",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Apocard Retard 100 mg",
  "name_fr": "Apocard Retard 100 mg",
  "name_nl": "Apocard Retard 100 mg",
  "amp_code": "SAM255001-00",
  "strengths": [
    "100.0000",
    "100.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Flecainide Acetate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Flecainide",
  "authorisation_numbers": [
    "BE255001"
  ]
}

See everything about flecainide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.